Dominic Schiavone is a Research Scientist for Fresenius Kabi USA, working within their Automated Blood Technologies and Chemistry Group. He has an undergraduate degree in Chemistry from Elmhurst College and a Master’s Degree in Chemistry from DePaul University, Chicago, Illinois. He has been part of the ISPE Process Validation conference planning committee for three years. He was part of ISPE team in developing a paper on Process Validation lifecycle implementation for existing (‘Legacy”) products issued in 2016. Dominic has been working in the pharmaceutical industry for the past 28 years with companies such as, G.D. Searle & Company, Pharmacia / Pfizer by acquisition, Baxter Healthcare and Smith and Nephew Solopak.